Further, Chu et al. [11] showed that RANKL protein administered by the intra-peritoneal route can induce prostate cancer bone colonization in mice, confirming the importance of the pathophysiological role of RANKL as both autocrine and paracrine factor. This evidence concerns the gene TNFSF11 and prostate cancer.